Our Mission: We will conduct clinical research trials in the field of infectious diseases with particular focus on the safety and comfort of our participants, quality of our data, and integrity of our results. We partner with pharmaceutical companies and government agencies to develop experimental therapies for both the prevention and treatment of infectious diseases.

CARE-ID is currently looking for volunteers to participate in various research studies. Feel free to click on any of the links below to find out more information on a specific study or visit our Clinical Trials page for an overview of all our currently enrolling studies.

Graceway Genital Warts Study
Research Study for Genital Warts.

Astellas 15L-CL-101

Research Study for Recurrent Genital Herpes.

VERxVE
The Verve Study: For HIV+ Individuals Who Have Never Been on Treatment.

Gilead Sciences Elvitegravir/Ritonavir vs. Raltegravir
CARE-ID is currently enrolling HIV-1+ infected treatment-experienced adults who are 18 years of age or older to take part in a clinical trial investigating the safety and efficacy of Ritonavir-boosted elvitegravir verses Raltegravir.

V212-002 Heat-Treated Varicella-Zoster Virus in HIV Infected Volunteers
A Phase I, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults.

The NEwArT Study

Join our clinical research study comparing 2 different treatment regimens in individuals who have never taken HIV medications before.